Baron Funds released Q1 2025 investor letter on Penumbra, noting how Trump-era tariffs and onshoring trends affect AI stocks.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Baron Funds released Q1 2025 investor letter on Penumbra, noting how Trump-era tariffs and onshoring trends affect AI stocks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Penumbra
medical device company in Alameda, California
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Coverage
Newest first; wire copies grouped- Insider MonkeyPenumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company ann